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Background/Objectives:  Parkinson’s disease is a neurodegenerative disease with cardinal features of tremor, 
rigidity, postural instability and bradykinesia. Surgery is indicated for the patients not responding to medical 
management or who develop motor fluctuations and dyskinesia following prolonged levodopa therapy. 
Stereotactic Subthalamotomy and VIM (Ventralis Intermedius) Thalamotomy is cheap, safe and effective surgical 
options for the treatment of Parkinsonian tremor. The objective of the study was to compare Stereotactic 
Subthalamotomy with Ventralis Intermedius (VIM) Thalamotomy, in terms of improvement in Unified Parkinson’s 
Disease Rating Scale (UPDRS), for the treatment of Parkinsonian tremor. 
Material and Methods:  This is a randomized control trial (RCT) and 38 tremor predominant Parkinsonian 
patients were enrolled in the study. Half of the patients underwent Stereotactic Subthalamotomy and another half 
underwent VIM Thalamotomy. Patients were assessed pre-operatively, immediately post-operatively and followed 
up at three weeks, six weeks and three months by using UPDRS scores. 
Results:  The mean age of patients was 59.58 years and they were predominantly male. Post-operative UPDRS 
score was improved significantly in both STN and VIM groups. However, the improvement was significantly 
higher in STN lesioning compared to VIM lesioning.On the other hand, the improvement in tremor component 
score of UPDRS was comparable in the both groups. Moreover, post-operative complications were higher 
following Subthalamotomy (21.05%) which included dyskinesia, dysphasia, transient weakness and hematoma 
formation. 
Conclusion:  Both Stereotactic Subthalamotomy and VIM Thalamotomy are equally effective in relieving 
Parkinsonian tremor with a lower complication rate following VIM Thalamotomy. 
Keywords:  Parkinson’s disease, Subthalamotomy, VIM Thalamotomy, Unified Parkinson’s disease Rating Score. 
Abbreviations:  VIM: Ventralis Intermedius. RCT: Randomized Control Trial. PD: Parkinson ’s disease. UPDRS: 
Unified Parkinson’s disease Rating Scale. DBS: Deep Brain Stimulation. STN: Subthalamic Nucleus. 
 
INTRODUCTION 
The study was aimed to compare the Stereotactic 
Subthalamotomy with Ventralis Intermedius (VIM) 
Thalamotomy, in terms of improvement in Unified 
Parkinson’s Disease Rating Scale (UPDRS), for the 
treatment of Parkinsonian tremor. 
 Parkinson’s disease (PD) is a progressive 
neurodegenerative disease with an incidence of 4.5 to 
21 per 100,000 populations per year, which is only 
second to Alzheimer’s disease.1 The average age of 
onset is 60 years with male predominance.2 Two major 
neuropathological findings in this disease are loss of 
pigmented dopaminergic neurons in substantia nigra 
and the presence of Lewy bodies and Lewy neuritis.3,4 
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Clinical diagnosis is made on the basis of four 
characteristic features: resting tremor, rigidity, postural 
instability and bradykinesia.5 
 Levodopa along with carbidopa, remains the 
standard medical treatment of motor symptoms of the 
disease. However, some patients present with motor 
fluctuations and dyskinesia with its long term use.6 
Thus, surgical treatment is reserved for patients with 
either decrease response to medical treatment or 
development of drug related complications. 
 Deep Brain Stimulation (DBS) of VIM (Ventralis 
Intermedius) nucleus or STN (Subthalamic nucleus) is 
a surgery of choice for Parkinsonian tremor but it is an 
expensive procedure. Alternate cheap, safe and 
effective surgical options are Stereotactic 
Subthalamotomy and VIM Thalamotomy. Today, the 
provision of magnetic resonance based images along 
with the development of SurgiPlan workstation with 
inbuilt digital brain atlas; the localization of target 
has become more precise. Furthermore, safe trajectory 
to the target can be defined avoiding sulci, ventricles 
and internal capsule reducing surgical morbidity. Final 
level of accuracy lies in functional mapping using 
pre-operative macro-electrode stimulation in awake 
before making permanent lesion using 
radiofrequency lesion generator.7 
 
MATERIAL AND METHODS 
Study Design and Setting 
It was the randomized control trial (RCT) conducted in 
the Department of Neurosurgery (Unit-II), Lahore 
General Hospital (LGH), Lahore, Pakistan from March 
2015 to February 2017 after clearance from the ethical 
committee. Non probability, purposive sampling 
technique was used. Thirty eight patients were 
enrolled in the study. Allocation of a particular 
procedure was done by random method. Half of the 
patients were operated via. Subthalamotomy and the 
other half were operated via. VIM Thalamotomy. 
Informed consents were taken from all patients 
fulfilling the inclusion criteria after explaining details 
of the procedure, outcome, and risks. 
 
Inclusion Criteria 
Patients included in the study were medically 
refractory Parkinsonian patients getting maximum 
doses of carbidopa (200 mg/day) and Levodopa (800 
mg/day) for at least 6 months and those who 
developed drug induced dyskinesia. 
Exclusion Criteria 
Patients with tremors due to stroke/infarction, head 
injury or demyelination; lesions in basal ganglia; those 
having malignant diseases, bleeding diathesis and 
cognitive decline were excluded from the study. 
 
Data Collection and Clinical Management 
Detail history and neurological assessment of enrolled 
patients were carried out and preoperative UPDRS was 
recorded. Pre-operatively MRI brain (non-contrast) 
was done in all patients to rule out any structural 
abnormality. All the Parkinsonian drugs were stopped 
one day before surgery. 
 
Procedure 
After application of stereotactic Leksell G frame under 
local anesthesia, MRI Brain with contrast was done 
and the image was transferred to SurgiPlan 
workstation. Then the target was calculated for 
Subthalamic nucleus (STN) and VIM nucleus using 
Laitinen formula. This acquired target on MRI was 
confirmed by superimposing on Shelton Bran digital 
brain atlas. Once the desired target was confirmed, 
the trajectory was determined with SurgiPlan avoiding 
sulci, ventricles, internal capsule and blood vessels. 
 The Leksell frame was fixed to the OT table 
adjusting X, Y, Z, arc and rings according to the 
calculations. A 14mm burr hole was made under local 
anesthesia. A stereotactic 2.1mm microelectrode was 
then inserted while the frame was adjusted in such a 
way that tips of electrode were -4mm above the target 
(zero). The electrode was connected through leads to 
the Cosman lesion generator with stimulation 
parameters set at a frequency of 130 Hz, voltage of 1.5 
Volts and pulse width of 0.2 milliseconds. The 
electrode was gradually advanced at 2mm interval till 
patient’s symptoms disappeared. During stimulation 
patients were evaluated for the disappearance of 
tremors and side effects of stimulation like 
contralateral tetanic contractions of arms and legs, 
contralateral deviation of eyes, any paresthesias or 
visual hallucinations. Once the target was 
physiologically confirmed, a permanent lesion was 
made by setting temperature at 50°C for one minute, 
then on 70°C and finally on 90°C for one minute. 
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Post-Operative Management 
Post-operatively, the patients 
were shifted to the recovery 
room and CT scan was obtained 
after 8 hours, to see any 
hematoma. The pre-op 
medications for Parkinsonism 
were restarted. Patients were 
evaluated in the next morning 
and UPDRS score along with 
any complications were 
recorded. An MRI scan with 
2mm cuts of T1W and T2W 
images was obtained to confirm 
the placement of lesion. Patients 
were then discharged on 
medications with doses 
readjusted in consultation with 
neurologist. Follow up was done 
with UPDRS score at 3 weeks, 6 
weeks and 3 months. 
 
Data Analysis 
Statistical analysis was done 
using Statistical Package for 
Social Sciences (SPSS) version 
22. The qualitative data like 
demographics were documented 
as percentage and frequency 
distribution tables and compared 
using chi-square test. The 
quantitative data like age were 
presented in Mean ± Standard 
Deviation. 
 After fulfilling the 
parametric test assumptions, 
paired sample t-test was used 
to compare differences before 
and after treatment in the 
UPDRS score and independent 
sample student’s t-test was 
applied to determine the 
significant differences between 
the UPDRS score of both 
groups. The p value of ≤ 0.05 
was considered as significant. 
 
RESULTS 
Thirty eight patients were
Table 1:  Distribution of Patient by Age in Both Study Groups. 
 








STN (n = 19) 61.00 5.48 50 70 
0.118 VIM (n = 19) 58.16 5.44 45 67 
Total (n = 38) 59.58 5.58 45 70 
 




STN Group VIM Group 
Bilateral tremor with mild rigidity and bradykinesia 7 (36.84%) 6 (31.58%) 
Predominant right sided tremor with mild rigidity 
± bradykinesia 
5 (26.31%) 7 (36.84%) 
Predominant left sided tremor with mild rigidity 
± bradykinesia 
4 (21.05%) 4 (21.05%) 
Unilateral tremor with bradykinesia 3 (15.78%) 2 (10.53%) 
Total 19 19 
 
Table 3:  Comparison of Duration of Disease and Treatment in Both Study Groups. 
 
 Study Groups Mean S.D Minimum Maximum P value 
Duration of 
Disease (Years) 
STN (n = 19) 9.16 3.55 3.00 15.00 
0.824 VIM (n = 19) 8.89 3.70 3.00 15.00 




STN (n = 19) 7.26 3.87 2.00 15.00 
0.970 VIM (n = 19) 7.32 4.62 2.00 15.00 
Total (n = 38) 7.29 4.20 2.00 15.00 
 
Table 4: Comparison between Pre-operative and Post-operative UPDRS Score in 
Subthalamotomy (STN) Group. 
 
 Mean SD t-test (p value) 
Pre-operative 19.32 1.797  
Paired Comparison 
Pre-operative vs. Immediate post-operative 7.95 1.224 33.92 (< 0.0001) 
Pre-operative vs. 3 weeks follow-up 7.89 0.994 40.92 (< 0.0001) 
Pre-operative vs. 6 weeks follow up 7.53 1.124 43.46 (< 0.0001) 
Pre-operative vs. 3 months follow-up 7.47 1.073 41.00 (< 0.0001) 
Immediate post-operative vs. 
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Table 5: Comparison between Pre-operative and Post-
operative UPDRS Scores in VIM Thalamotomy 
Group. 
 
 Mean SD t-test (p value) 

















45.47 (< 0.0001) 
Pre-operative vs. 






47.58 (< 0.0001) 
Pre-operative vs. 






34.55 (< 0.0001) 
Immediate post-operative vs. 








included in our study, 19 each in VIM Thalamotomy 
and Subthalamotomy (STN) group. 
 
Gender Distribution: 
There were 14 (73.68%) male and 5 (26.32%) females 
in the STN group while 17 (89.47%) male and 2 
(10.53%) females in VIM group, p-value > 0.05. 
 
Distribution of Patient by Age: 
Overall mean age of the patients was 59.58 ± 5.44 
years. The mean age in VIM and STN group was 61 ± 
5.48 and 58.16 ± 5.44 years, respectively (Table 1). 
 
Distribution of Patients According to Presenting 
Complaints: 
Majority of the patients presented with bilateral 
symptoms (tremor, rigidity and bradykinesia) in both 
the groups followed by predominantly right sided 
tremor, rigidity and bradykinesia. Presentation with 
only unilateral tremor was least common in both VIM 
Thalamotomy and Subthalamotomy groups (Table 2). 
 
Duration of Disease and Treatment: 
The mean duration of disease in STN group and VIM 
group was 9.16 ± 3.55 years and 8.89 ± 3.70 years 
respectively whereas, the mean duration of treatment 
in STN group was 7.26 ± 3.87 years and VIM group 
was 7.32 ± 4.62 years, with no statistical difference 
between means (Table 3). 
 
Comparison between Pre-operative and Post-
operative UPDRS Scores in Subthalamotomy 
Group: 
The mean UPDRS score was significantly reduced in 
immediate post-operative period when compared to 
pre-operative score and the improvement was 
persistently sustained throughout the 3 weeks, 6 weeks 
and 3 months follow-up. Similarly, after 3 months of 
procedure the mean UPDRS score was improved 
significantly when compared to post-operative score 
with p < 0.05 (Table 4). 
 
Comparison between Pre-operative and Post-
operative UPDRS Scores in VIM Thalamotomy 
Group: 
The mean UPDRS score was significantly reduced in 
immediate post-operative period when compared to 
pre-operative score and the improvement was 
persistently sustained throughout the 3 weeks, 6 weeks 
and 3 months follow-up. Similarly, after 3 months of 
procedure the mean UPDRS score was improved 
significantly when compared to post-operative score 
with p < 0.05 (Table 5). 
 
Comparison of UPDRS Scores between 
Subthalamotomy (STN) and VIM Thalamotomy 
Groups: 
The difference in mean pre-operative UPDRS score 
between STN (19.32 ± 1.80) and VIM (18.58 ± 1.6) 
was not statistically significant (p = 0.191). After 
surgery, it was observed as 7.95 ± 1.22 in STN group 
and 9.0 ± 1.11 in VIM group. This shows statistically 
significant improvement in UPDRS score following 
Subthalamotomy compared to VIM Thalamotomy. It 
was observed that improvement in terms of UPDRS 
score was significantly more and sustained throughout 
3 weeks, 6 weeks and 3 months follow-up in STN 
group as compared to VIM Thalamotomy group with 
p < 0.05 (Table 6). 
 
Comparison of Mean Tremor Component score 
of UPDRS Before and After Surgery in 
Subthalamotomy (STN) Group: 
The mean pre-operative tremor component score of 
UPDRS score was significantly reduced after
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Table 6: Comparison of UPDRS Score in Both Study Groups. 
 
UPDRS Score Study Groups Mean   S.D  Minimum   Maximum   t-test (p value) 
Pre-operative 
STN (n = 19) 19.32 1.80 17 23 
1.33 (0.191) VIM (n = 19) 18.58 1.61 16 22 
Total (n = 38) 18.95 1.72 16 23 
Post-operative 
STN (n = 19) 7.95 1.22 6 10 
-2.78 (0.009) 
VIM (n = 19) 9.00 1.11 7 11 
3 weeks 
STN (n = 19) 7.89 0.99 6 10 
-2.63 (0.012) 
VIM (n = 19) 8.84 1.21 7 11 
6 weeks 
STN (n = 19) 7.53 1.12 6 10 
-3.04 (0.004) 
VIM (n = 19) 8.63 1.12 7 11 
3 months 
STN (n = 19) 7.47 1.07 6 9 
-2.76 (0.009) 
VIM (n = 19) 8.53 1.26 7 11 
 
and 3 months with p < 0.05. 
Similarly, while comparing 
immediate post-operative score with 
3 months follow up score, the 
improvement was statistically 
significant (table 7). 
 
Comparison of Mean Tremor 
Component Score of UPDRS 
before and After Surgery in VIM 
Thalamotomy Group: 
The mean pre-operative tremor 
component score of UPDRS score 
was significantly reduced after 
surgery and during subsequent follow 
up at 3 weeks, 6 weeks and 3 months 
with p < 0.05. Similarly, while 
comparing immediate post-operative 
score with 3 months follow up score, 
the improvement was statistically 
significant (table 8). 
 
Comparison of Tremor 
Component Score of UPDRS 
between Two Study Groups: 
The mean pre-operative tremor 
component of UPDRS score was 2.63 
± 0.49 and 2.57 ± 0.50 in STN and 
VIM group respectively, the 
difference was not statistically 
significant (p = 0.748). The mean 
tremor component was 0.78 ± 0.71 in 
 
Table 7: Comparison of Mean Tremor Component Score of UPDRS before 
and After Surgery in Subthalamotomy (STN) Group. 
 
 
Tremor component of 
UPDRS score (Mean) 
SD t-test (p value) 









8.93 (< 0.001) 
Pre-operative vs. 






10.01 (< 0.001) 
Pre-operative vs. 






12.44 (< 0.001) 
Pre-operative vs. 






12.44 (< 0.001) 
Immediate post-operative vs. 








Table 8: Comparison of Mean Tremor Component Score of UPDRS before 
and After Surgery in VIM Thalamotomy Group. 
 
 
Tremor component of 






































Immediate post-operative vs. 
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STN group and 0.73 ± 0.0.65 in VIM group during 
immediate post-operative period which was not 
significantly different. Similarly, difference in 
improvement in tremor scores between two groups 
during subsequent follow up at 3 weeks, 6 weeks and 3 
months was also comparable statistically (Table 9). 
 
Table 9: Comparison of Tremor Component of UPDRS 
Score in Both Study Groups. 
 
Tremor Component 
of UPDRS Score 
Procedure Mean S.D P value 
Pre-operative 
STN (n = 19) 2.63 0.49 
0.748 
VIM (n = 19) 2.57 0.50 
Immediate post-
operative 
STN (n = 19) 0.78 0.71 
0.814 
VIM (n = 19) 0.73 0.65 
3 weeks follow-up 
STN (n = 19) 0.68 0.67 
0.778 
VIM (n = 19) 0.73 0.45 
6 weeks follow up 
STN (n = 19) 0.52 0.51 
0.752 
VIM (n = 19) 0.57 0.50 
3 months follow up 
STN (n = 19) 0.52 0.52 
0.753 
VIM (n = 19) 0.57 0.50 
 
Post-operative Complications 
Overall, 10.52% and 21.05% complications occurred 
in VIM and STN groups, respectively (p < 0.05). One 
patient in VIM group had surgical site infection that 
was treated with antibiotics. One patient in each group 
had transient weakness that improved within few 
weeks. Similarly, three more complications were 
encountered in STN group (dyskinesia, dysphasia and 
small intraparenchymal hematoma). Dyskinesia in 
contralateral upper limb was managed with 
readjustment of anti-Parkinsonian medications and 
disappeared completely at the end of 3 months. 
Similarly, expressive dysphasia was seen in one 
patient who showed gradual improvement during 
subsequent follow-up. Small intraparenchymal 
hematoma (volume < 10 ml) in one patient was 
managed conservatively (Table 10). 
 






Wound infection 1 (5.26%) 0 (0%) 
Transient weakness 1 (5.26%) 1 (5.26%) 
Dyskinesia 0 (0%) 1 (5.26%) 
Dysphasia 0 (0%) 1 (5.26%) 
Small hematoma 0 (0%) 1 (5.26%) 
DISCUSSION 
Parkinson’s disease is a progressive neurodegenerative 
disease affecting middle age to elderly population. 
Onset of the disease is after sixth decade of life and 
less than 4% of the Parkinsonian patients are below 50 
years of age.8 The mean age of presentation in our 
study is 59.58 years with range of 45 – 70 years. 
Progression of the disease with age is attributed to 
progressive degeneration of dopaminergic neurons in 
substantia nigra.9 The disease is more common in men 
than women (gender ratio: 1.5:1–2:1).2,8 The male to 
female ratio in our study was 4.4:1. This ratio is high 
compared to other international studies owing to 
differences in the referral pattern. 
 Patients with Parkinson’s disease develop motor 
symptoms gradually over the years with progressive 
degeneration of dopaminergic neurons. Clinical 
manifestations appear when more than 50% 
dopaminergic neuronal loss has occurred. The mean 
duration of disease before seeking surgical 
intervention in our study was 9.03 years with varying 
range of 3 to 15 years. Similar results were seen in 
patients undergoing VIM Thalamotomy in Fraix et al. 
study (mean age of 8 years and range of 1-19 years) 
and patients undergoing Subthalamotomy in Alvarez 
et al study (mean age of 10.8 years and rage of 5 – 27 
years).10,11 
 Patients receive anti-Parkinsonian medications for 
a variable period of time before they develop motor 
fluctuations and dyskinesia with escalating doses. In 
our study, the mean duration of medical treatment 
before surgical intervention was 7.29 years with range 
of 2 to 15 years. Olanow et al. estimated that as many 
as 50% of Parkinsonian patients on levodopa for five 
years develop motor fluctuations and dyskinesia.12 
Motor complications are more frequent in younger 
onset of the disease. In our study four patients 
presented with dyskinesia. 
Comparison of Stereotactic Subthalamotomy and Ventralis Intermedius (VIM) Thalamotomy in Relieving 
http//www.pakjns.org         Pak. J. of Neurol. Surg. – Vol. 24, No. 3, Jul. – Sep., 2020         -222- 
 Both, Stereotactic VIM Thalamotomy and 
Subthalamotomy were associated with significant 
improvement in post-operative UPDRS scores. In a 
study conducted by Sobstyl et al., among 41 tremor 
predominant PD patients who underwent VIM 
Thalamotomy, the mean preoperative UPDRS of 11.2 
improved to 2.67. Similar results were seen in Boecker 
et al. study following VIM Thalamotomy in tremor 
dominant Parkinsonian patients13. Following 
Subthalamotomy by Tarsy et al. in 89 Parkinsonian 
patients, UPDRS scores while off medication 
improved by 50% at 12 months.14 A study by patel 
et al. in 2003, showed that Stereotactic lesioning of 
STN in 21 Parkinsonian patients had significant 
improvement in rigidity, contralateral tremor and 
bradykinesia with maximum effect on tremor 
component. There was a significant improvement in 
the UPDRS scores on medication and off medication 
at 6, 12 and 24 months follow up15.In another study by 
Su et al. in 2002, STN lesioning in 12 patients with 12 
months follow up showed improvement in UPDRS 
scores by 30% in off period, 38% in on period.16 
 In our study, improvement in mean post-operative 
UPDRS score was significantly higher in 
Subthalamotomy group compared to VIM 
Thalamotomy group. This difference in two groups 
was persistent throughout 3 weeks, 6 weeks and 3 
months follow-up. This significant difference in two 
groups may be attributed to the fact that STN lesioning 
is associated with post-operative improvement in not 
only the tremor component but also rigidity, 
bradykinesia and postural instability.16 On the other 
hand VIM lesioning has no or minimal effect on 
rigidity, bradykinesia and rigidity.17 
 We also studied the tremor component of UPDRS 
score separately. The mean pre-operative tremor 
component score in STN group was 2.63. Nine 
patients (47.36%) had complete cessation of tremor at 
3 months follow up while ten patients had significant 
improvement with mean score of 0.53 at latest follow-
up. Similarly, mean pre-operative tremor score in VIM 
group was 2.58. Eight patients (42.1%) had complete 
cessation of tremor at 3 months follow-up while 11 
patients had significant improvement with mean score 
of 0.58 at latest follow-up. Jankovic et al. in 1995 
conducted a retrospective study among 42 patients 
who underwent Stereotactic VIM Thalamotomy for 
Parkinsonian tremor. During follow up 86% of 
patients had complete cessation or significant 
improvement in contralateral tremor.18 Similar results 
were shown by Balás et al. in 2001, where he 
conducted Thalamotomy in 34 tremor predominant 
Parkinsonian patients with 12 months average follow-
up. The result showed 88% of patients with complete 
cessation or marked improvement in contralateral 
tremor.19 Alvarez et al. in 2009 studied the role of 
Subthalamotomy in 68 Parkinsonian patients which 
showed tremor score of 2.2 pre-operatively improved 
to 0.2 at 12 months follow-up.11 
 There was no significant difference in terms of 
improvement in tremor scores between two groups. No 
study is available in literature review comparing STN 
and VIM lesioning. However, Parihar et al. in 2015 
compared the results of VIM and STN stimulation 
(DBS) in Parkinsonian tremor. The degree of 
improvement in postural or action tremor scores 
between VIM DBS and STN DBS was not 
significantly different. Postural/action tremor 
improved 72% in the VIM DBS group and 68% in the 
STN group.20 
 Post-operative complications were higher in 
stereotactic STN lesioning (21.05%) compared to VIM 
lesioning (10.52%). There was no mortality or 
cognitive impairment in both groups. Our results were 
comparable with other international studies. Jancovic 
et al. encountered immediate postoperative 
complications in 58% of patients following VIM 
lesioning with most common being contralateral 
weakness (34%) followed by dysarthria (29%) and 
confusion (23%). But these complications rapidly 
resolved during post-operative period18. Similarly, in a 
study conducted by Sobstyl et al. in 41 tremor 
predominant Parkinsonian patients who underwent 
stereotactic VIM Thalamotomy, 13 patients had 
transient and 6 had permanent complications7. In a 
case series of 89 Subthalamotomy conducted by 
Alvarez et al., 52 patients developed contralateral 
dyskinesia that resolved gradually in 38 cases. 
However, 14 patients had hemiballism and chorea 
which required Pallidotomy11. Relatively higher 
incidence of complications in STN group may be due 
to a small target of Subthalamic nucleus. Thus, 
macroelectrode monitoring helps proper localization of 
the target and prevents possible complications. 
 Recently, MR-guided high intensity focused 
ultrasound lesioning of VIM and Subthalamic nucleus 
has been considered safe and effective in treatment of 
Parkinsonian patients with lower complications rate 
like dysphagia and dysarthria21. Similarly, using 
modern functional Stereotactic Radiosurgery (SRS) 
parameters, radiosurgery Thalamotomy has become a 
safe and useful procedure for patients who are not 
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suitable for an open surgical procedure. The reported 
results and complications of SRS are comparable to 
those of thalamic lesions generated by radiofrequency 
procedures. However, further studies are necessary to 
establish the role of SRS targeting the STN, since its 
small size and complex anatomical relationships make 
this nucleus less suitable for the procedure.22 
 
CONCLUSION 
Both Stereotactic VIM Thalamotomy and 
Subthalamotomy are equally effective in relieving 
tremor in tremor predominant Parkinsonism. However, 
overall improvement in total UPDRS score is 
significantly higher following STN lesioning 
compared to VIM lesioning. And this improvement 
comes at a cost of higher complication rate compared 
to VIM Thalamotomy. 
 
REFERENCES 
1.  Muangpaisan W, Mathews A, Hori H, Seidel D. A 
systematic review of the worldwide prevalence and 
incidence of Parkinson's disease. J Med Assoc Thai. 
2011; 94 (6): 749-755. 
2.  Twelves D, Perkins KS, Counsell C. Systematic review 
of incidence studies of Parkinson’s disease. Mov 
Disord. 2003; 18: 19–31. 
3. Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, 
Macias R, Bezard E, Obeso JA. Initial clinical 
manifestations of Parkinson’s disease: features and 
pathophysiological mechanisms. Lancet Neurol. 2009; 
8: 1128–1139. 
4.  Rodrigues e Silva AM, Geldsetzer F, Holdorff B, 
Kielhorn FW, Balzer-Geldsetzer M, Oertel WH, Hurtig 
H, Dodel R. Who was the man who discovered the 
“Lewy bodies”? Mov Disord. 2010; 25: 1765–1773. 
5.  Wirdefeldt K, Adami HO, Cole P, Trichopolous D and 
Mandel J. Epidemiology and Etiology of Parkinson 
disease: a review of the evidence. Eur J Epidemio. 
2011; 26 (1): 51-58. 
6.  Mazzucchi S., Frosini D., Bonuccelli U., Ceravolo R. 
Current treatment and future prospects of dopa-induced 
dyskinesias. Drugs Today (Barc). 2015; 51 (5): 315-
329. 
7.  Sobstyl M, Zabek M, Koziara H, Kadziołka B, 
Mossakowski Z. Unilateral thalamotomy for the 
treatment of tremor dominant Parkinson’s disease. 
Neurol Neurochir Pol. 2006; 40 (2): 119-126. 
8.  Van Den Eeden SK, Tanner CM, Bernstein AL, Fross 
RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of 
Parkinson's disease: variation by age, gender, and race/ 
ethnicity. Am J Epidemiol. 2003; 157 (11): 1015-1022. 
9.  Lee A, Gilbert RM. Epidemiology of Parkinson 
Disease. Neurol Clin. 2016; 34 (4): 955-965. 
10.  Fraix V, Pollak P, Moro E, Chabardes S, Xie J, Ardouin 
C, Benabid AL. Subthalamic nucleus stimulation in 
tremor dominant Parkinsonian patients with previous 
thalamic surgery. J Neurol Neurosurg Psychiatry, 2005; 
76: 246–248. 
11.  Alvarez L, Macias R, Pavón N, López G, Rodríguez-
Oroz MC, Rodríguez R, Alvarez M, Pedroso I, Teijeiro 
J, Fernández R, Casabona E, Salazar S, Maragoto C, 
Carballo M, García I, Guridi J, Juncos JL, DeLong MR, 
Obeso JA. Therapeutic efficacy of unilateral 
Subthalamotomy in Parkinson's disease: results in 89 
patients followed for up to 36 months. J Neurol 
Neurosurg Psychiatry, 2009; 80 (9): 979-985. 
12.  Olanow CW, Watts RL, Koller WC. An algorithm 
(decision tree) for the management of Parkinson's 
disease (2001): treatment guidelines. Neurology, 2001; 
56: S1. 
13.  Boecker H, Wills AJ, Ceballos-Baumann A, Samuel M, 
Thomas DG, Marsden CD, Brooks DJ. Stereotactic 
thalamotomy in tremor-dominant Parkinson's disease: 
an H2 (15) O PET motor activation study. Ann Neurol. 
1997; 41 (1): 108-111. 
14.  Tarsy D. Does subthalamotomy have a place in the 
treatment of Parkinson's disease? J Neurol Neurosurg 
Psychiatry, 2009; 80: 939. 
15.  Patel NK, Heywood P, O'Sullivan K, McCarter R, Love 
S, Gill SS. Unilateral subthalamotomy in the treatment 
of Parkinson's disease. Brain, 2003; 126: 1136–1145. 
16.  Su PC, Tseng HM, Liu HM, Yen RF, Liou HH. 
Subthalamotomy for advanced Parkinson disease. J 
Neurosurg. 2002; 97: 598–606. 
17.  Chao Y, Gang L, Na ZL, Ming WY, Zhong WS, Mian 
WS. Surgical Management of Parkinson's disease: 
Update and Review. Interv Neuroradiol. 2007; 13 (4): 
359–368. 
18.  Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. 
Outcome after stereotactic thalamotomy for 
Parkinsonian, essential and other types of tremor. 
Neurosurgery, 1995; 37 (4): 680-687. 
19.  Balás I. et al. Stereotactic Thalamotomy for 
Parkinsonian and others types of tremor: Experiences of 
thalamic multiunit burst activity by means of semi-
microelectrode. Rev Neurol. 2001; 32(16): 520-524. 
20.  Parihar R, Alterman R, Papavassiliou E, Tarsy D, Shih 
LC. Comparison of VIM and STN DBS for 
Parkinsonian Resting and Postural/Action Tremor. 
Tremor Other Hyperkinet Mov (N Y). 2015; 5: 321. 
21.  S. Hägele-Link, N.A. Wegener, S.R. Schreglmann, J. 
Rosenfeld, M. Mueller-Baumberger, R. Bauer, A. 
Lebeda, B. Werner, E. Martin, G. Kägi. Transcranial 
unilateral MR guided high intensity focused ultrasound 
in Parkinson’s disease or essential tremor seems to be 
save concerning dysphagia and dysarthria. Mov Disord. 
2016: 31. 
22.  Frighetto L, Bizzi J, Annes RD, Silva Rdos S, Oppitz P. 
Comparison of Stereotactic Subthalamotomy and Ventralis Intermedius (VIM) Thalamotomy in Relieving 
http//www.pakjns.org         Pak. J. of Neurol. Surg. – Vol. 24, No. 3, Jul. – Sep., 2020         -224- 





Disclosures:  Authors report no conflict of interest. 
Ethical Review Board Approval:  The study was conformed to the ethical review board requirements. 
Human Subjects:  Consent was obtained by all patients/participants in this study. 
Conflicts of Interest: 
In compliance with the ICMJE uniform disclosure form, all authors declare the following: 
Financial Relationships:  All authors have declared that they have no financial relationships at present or within the 
previous three years with any organizations that might have an interest in the submitted work. 
Other Relationships:  All authors have declared that there are no other relationships or activities that could appear to have 




Address for Correspondence: 
Somraj Lamichhane 







Sr.# Author’s Full Name Intellectual Contribution to Paper in Terms of: 
1. Somraj Lamichhane Study design and methodology. 




Date of Submission: 31-07-2020 
Date of Revision: 11-08-2020 
Date of Online Publishing: 25-09-2020 
Date of Print: 30-09-2020 
 
 
 
